Pregnancy & lactation.
Emulsion gel Avoid contact to eyes or mucous membranes. Do not apply to skin wounds or open injuries. Severe cutaneous reactions including Stevens-Johnson syndrome & toxic epidermal necrolysis (Lyell's syndrome). Monitor for sign of hypersensitivity reaction. Discontinue use if rash occurs. Childn.
Inj Small increased risk of serious CV thrombotic events (including MI & stroke) particularly at high dose & in long-term treatment. Periodically re-evaluate patient's need for symptomatic relief & response to therapy especially when initial inj treatment continues w/ diclofenac tab or supp for >4 wk. Advise patients to remain alert for signs & symptoms of serious arteriothrombotic events (eg, chest pain, shortness of breath, weakness, speech slurring). Patients w/ symptoms of GI disease, history suggestive of GI ulcerative colitis, Crohn's disease, pre-existing dyshaemopoiesis or blood coagulation disorders; severe hepatic, cardiac or renal impairment. W/draw treatment if peptic ulceration or GI bleeding occurs. Monitor hepatic & renal function of elderly during prolonged treatment.
Sign Out
